POLR1G
Basic information
Region (hg38): 19:45406644-45410737
Previous symbols: [ "CD3EAP" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the POLR1G gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 32 | 36 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 10 | 10 | 20 | |||
Total | 0 | 0 | 32 | 12 | 13 |
Variants in POLR1G
This is a list of pathogenic ClinVar variants found in the POLR1G region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-45406700-G-A | not specified | Uncertain significance (Jun 03, 2024) | ||
19-45406703-G-A | not specified | Uncertain significance (Sep 15, 2021) | ||
19-45406707-C-T | not specified | Uncertain significance (Feb 28, 2024) | ||
19-45407106-T-C | not specified | Uncertain significance (Jan 26, 2022) | ||
19-45407107-C-G | not specified | Uncertain significance (Jun 06, 2023) | ||
19-45407135-C-G | not specified | Uncertain significance (Oct 26, 2022) | ||
19-45408198-G-A | not specified | Uncertain significance (Jan 26, 2023) | ||
19-45408204-G-A | not specified | Uncertain significance (Dec 06, 2022) | ||
19-45408224-T-C | not specified | Uncertain significance (Aug 17, 2022) | ||
19-45408243-C-T | not specified | Uncertain significance (Apr 07, 2023) | ||
19-45408255-C-T | not specified | Uncertain significance (Mar 28, 2023) | ||
19-45408273-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
19-45408377-C-T | not specified | Uncertain significance (May 23, 2023) | ||
19-45408417-G-A | not specified | Uncertain significance (Sep 26, 2023) | ||
19-45408444-C-T | not specified | Uncertain significance (Mar 02, 2023) | ||
19-45408504-T-C | not specified | Uncertain significance (Jan 23, 2024) | ||
19-45408536-G-T | not specified | Uncertain significance (Aug 17, 2022) | ||
19-45408593-G-A | not specified | Uncertain significance (Jan 09, 2024) | ||
19-45408612-A-C | not specified | Uncertain significance (May 15, 2024) | ||
19-45408645-C-G | not specified | Uncertain significance (Oct 10, 2023) | ||
19-45408653-C-T | not specified | Uncertain significance (Apr 23, 2024) | ||
19-45408720-A-G | not specified | Uncertain significance (Jul 13, 2022) | ||
19-45408744-A-C | Benign (Jan 30, 2024) | |||
19-45408812-A-G | Cerebrooculofacioskeletal syndrome 4 • not specified • ERCC1-related disorder | Benign (Oct 28, 2020) | ||
19-45408851-G-C | not specified | Uncertain significance (Apr 04, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
POLR1G | protein_coding | protein_coding | ENST00000309424 | 3 | 4558 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0316 | 0.620 | 125385 | 0 | 91 | 125476 | 0.000363 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.348 | 270 | 287 | 0.942 | 0.0000156 | 3258 |
Missense in Polyphen | 75 | 76.877 | 0.97559 | 941 | ||
Synonymous | 0.0381 | 120 | 121 | 0.996 | 0.00000681 | 1094 |
Loss of Function | 0.245 | 2 | 2.41 | 0.829 | 1.02e-7 | 33 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00338 | 0.00338 |
European (Non-Finnish) | 0.000115 | 0.000114 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000820 | 0.000816 |
dbNSFP
Source:
- Function
- FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Component of RNA polymerase I which synthesizes ribosomal RNA precursors. Isoform 1 is involved in UBTF-activated transcription, presumably at a step following PIC formation.;
- Pathway
- B-WICH complex positively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;NoRC negatively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;Epigenetic regulation of gene expression;Gene expression (Transcription);RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase I Chain Elongation
(Consensus)
Recessive Scores
- pRec
- 0.122
Intolerance Scores
- loftool
- 0.774
- rvis_EVS
- 1.73
- rvis_percentile_EVS
- 96.6
Haploinsufficiency Scores
- pHI
- 0.230
- hipred
- N
- hipred_score
- 0.412
- ghis
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.916
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cd3eap
- Phenotype
Gene ontology
- Biological process
- transcription initiation from RNA polymerase I promoter;termination of RNA polymerase I transcription;transmembrane receptor protein tyrosine kinase signaling pathway;rRNA transcription;positive regulation of gene expression, epigenetic
- Cellular component
- RNA polymerase I transcription factor complex;fibrillar center;nucleus;nucleoplasm;chromosome;nucleolus;mitochondrion;cytosol
- Molecular function
- RNA binding;DNA-directed 5'-3' RNA polymerase activity